Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
In all, 661 of 680 centers in 48 countries reported 37 818 hematopoietic SCT (HSCT) in 33 678 patients (14 165 allogeneic (42%), 19 513 autologous (58%)) in the 2012 survey. Main indications were leukemias, 10 641 (32%; 95% allogeneic); lymphoid neoplasias, 19 336 (57%; 11% allogeneic); solid tumors, 1630 (5%; 3% allogeneic); and nonmalignant disorders, 1953 (6%; 90% allogeneic). There were more unrelated donors than HLA-identical sibling donors (54% versus 38% (8% being mismatched related donor HSCT)). Cord blood was almost exclusive in allogeneic transplants (5% of total). Since 2011, the highest increases in allogeneic HSCT were for AML in CR1 (12%) and for myeloproliferative neoplasm (15%). For autologous HSCT the main increases were for plasma cell disorders (7%), non-Hodgkin lymphoma (4%) and autoimmune disease (50%). There were 4097 pediatric patients <18 years of age receiving HSCT, 2902 received an allogeneic and 1195 an autologous HSCT. Overall, 69% of allogeneic and 64% of autologous HSCT were performed in dedicated pediatric centers and the remainder in combined adult and pediatric centers. Distributions of diseases, donor types and stem cell source for all patients and pediatric patients in particular are shown. A percentage of centers fulfilling the annual required criteria for patient numbers for JACIE accreditation are provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hematopoietic Stem-Cell Transplantation
Copelan, E. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052638 · Cited by 2,522
Cited by
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease
Kröger, N., Solano, C., Wolschke, C., Bandini, G., Patriarca, F., Pini, M., Nagler, A., Selleri, C., Risitano, A., Messina, G., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1506002 · Cited by 573
Self-citationHematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually
for the European Society for Blood and Marrow Transplantation (EBMT), Passweg, J. R., Baldomero, H., Bader, P., Bonini, C., Cesaro, S., Dreger, P., Duarte, R. F., Dufour, C., Kuball, J., et al. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.20 · Cited by 402
Self-citationfor the European Society for Blood and Marrow Transplantation (EBMT), Passweg, J. R., Baldomero, H., Bader, P., Bonini, C., Duarte, R. F., Dufour, C., Gennery, A., Kröger, N., Kuball, J., et al. (2017) · Bone Marrow Transplantation · doi:10.1038/bmt.2017.34 · Cited by 395
Self-citationHematopoietic stem cell transplantation-50 years of evolution and future perspectives
Henig, I., & Zuckerman, T. (2014) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10162 · Cited by 209
“Rambam Maimonides Med J 2014;5 (4):e0028.”
Pediatric AML: From Biology to Clinical Management
De Rooij, J., Zwaan, C., & Van den Heuvel-Eibrink, M. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4010127 · Cited by 208
“Currently, several trials include minimal residual disease (MRD) levels after Courses 1 or 2 in risk stratification for SCT [37–40].”
Background
Metadata
- Authors
- for the European Society for Blood and Marrow Transplantation EBMT, Passweg, J. R., Baldomero, H., Peters, C., Gaspar, H. B., Cesaro, S., Dreger, P., Duarte, R. F., Falkenburg, J. H. F., Farge-Bancel, D., Gennery, A., Halter, J., Kröger, N., Lanza, F., Marsh, J., Mohty, M., Sureda, A., Velardi, A., & Madrigal, A.
- Venue
- Bone Marrow Transplantation
- Published
- 2014-03-17
- Volume
- 49
- Issue
- 6
- Pages
- 744-750
- ISSN
- 0268-3369 (ISSN-L)
- 1476-5365
- OpenAlex
- W2169721813
- Cited by
- 178
- References
- 1
- FWCI
- 16.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.